Related Experiment Video
Updated: May 7, 2026
08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
[Genetics of amyotrophic lateral sclerosis]
A Hübers1, J H Weishaupt, A C Ludolph
1Klinik für Neurologie, Universitätsklinikum Ulm, Universität Ulm, Oberer Eselsberg 45, 89081, Ulm, Deutschland.
Der Nervenarzt
|September 28, 2013
Summary
Amyotrophic lateral sclerosis (ALS) genetics are complex, with new gene discoveries like TDP-43, FUS, and C9ORF72 expanding our understanding of this motor neuron disease.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Amyotrophic lateral sclerosis (ALS) is a severe, fast-progressing neurodegenerative disease affecting motor neurons.
- Clinical signs include rapid muscle atrophy and weakness in limbs.
- Recent genetic research has significantly advanced the understanding of ALS.
Purpose of the Study:
- To review the evolving genetic landscape of Amyotrophic Lateral Sclerosis (ALS).
- To highlight key genetic discoveries and their implications for disease pathogenesis.
- To discuss the expansion of phenotypes associated with ALS genetics.
Main Methods:
- Literature review of recent genetic studies in ALS.
- Analysis of gene mutations and repeat expansions.
- Correlation of genetic findings with clinical phenotypes.
Main Results:
- The SOD gene remains significant, but mutations in TDP-43 and FUS are increasingly recognized.
- A hexanucleotide repeat expansion in the C9ORF72 gene is the most frequent genetic cause of ALS.
- Other less common genes contribute to understanding ALS pathogenesis.
- Genetic factors are linked to a broader spectrum of ALS clinical presentations.
Conclusions:
- The genetic basis of ALS is multifaceted and has significantly expanded.
- Understanding these genetic factors is crucial for unraveling ALS pathogenesis.
- Genetic discoveries are broadening the clinical understanding and potential therapeutic targets for ALS.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...